Miskolc, Hungary Clinical Trials

A listing of Miskolc, Hungary clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 69 clinical trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

IBP-9414 will be evaluated in preterm infants with a birth weight of 500-1500g, compared to placebo with regards to efficacy and safety in the prevention of necrotizing enterocolitis.

Szszb County Hospital and J sa Andr s University Teaching Hospital
 (43.4 away) Contact site
  • 1 views
  • 08 Apr, 2021
  • +72 other locations
Study to Explore the Efficacy and Safety of BIO89-100 in Subjects With Severe Hypertriglyceridemia

This study is designed to assess the efficacy, safety, and tolerability of different doses and dose regimens (QW or every 2 weeks [Q2W]), subcutaneous (SC) dosing of BIO89-100 compared to placebo in subjects with Severe Hypertriglyceridemia (SHTG).

Debreceni Egyetem
 (54.3 away) Contact site
  • 0 views
  • 05 Jun, 2021
  • +39 other locations
Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

The purpose of this study is to evaluate the effect of Sodium Zirconium Cyclosilicate (SZC) on arrhythmia-related cardiovascular outcomes in participants on chronic hemodialysis with recurrent hyperkalemia.

Research Site
 (1.4 away) Contact site
  • 2 views
  • 26 Sep, 2021
  • +272 other locations
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

remission
crohn's disease
CRU Hungary Kft
 (0.8 away) Contact site
  • 1037 views
  • 22 Feb, 2021
  • +807 other locations
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

remission
abdominal pain
crohn's disease
CRU Hungary Kft
 (0.8 away) Contact site
  • 858 views
  • 23 Feb, 2021
  • +780 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Miskolci Semmelweis Korhaz es /ID# 201285
 (0.8 away) Contact site
  • 630 views
  • 26 Sep, 2021
  • +926 other locations
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

immunomodulators
corticosteroids
abdominal pain
endoscopy
crohn's disease
CRU Hungary Kft
 (0.8 away) Contact site
  • 412 views
  • 12 Mar, 2021
  • +387 other locations
A Study to Evaluate the Efficacy Safety and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

The purpose of this study is to evaluate the efficacy and safety of guselkumab in pediatric participants aged greater than or equal to 6 through less than 18 years with chronic plaque psoriasis.

guselkumab
plaque psoriasis
phototherapy
etanercept
topical agents
Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz
 (1.4 away) Contact site
  • 51 views
  • 14 Aug, 2021
  • +49 other locations
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.

stroke
myocardial infarction
arterial disease
diabetes
infarct
Research Site
 (0.8 away) Contact site
  • 542 views
  • 26 Sep, 2021
  • +1336 other locations
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over express c-Met (c-Met+) best suited for telisotuzumab vedotin therapy in the second line or third line setting (Stage 1) and then to expand the group(s) to further evaluate efficacy in the selected population(s) (Stage …

cancer chemotherapy
c-MET
cancer treatment
EGFR
stage iv non-small cell lung cancer
CRU Hungary Egeszsegugyi s Szolgaltato Kft. /ID# 204878
 (0.8 away) Contact site
  • 119 views
  • 26 Sep, 2021
  • +380 other locations